Results 171 to 180 of about 37,080 (198)

Responses to medical treatment in patients with metastatic unresectable small intestinal neuroendocrine tumors - A single center study of 378 patients. [PDF]

J Neuroendocrinol
Slott C, Langer SW, Oturai P, Møller S, Hansen CP, Kjaer A, Holmager P, Klose M, Garbyal RS, Knigge U, Andreassen M.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Octreotide and Octreotide-derived delivery systems

Journal of Drug Targeting, 2023
Pharmaceutical peptide Octreotide is a somatostatin analog with targeting and therapeutic abilities. Over the last decades, Octreotide has been developed and approved to treat acromegaly and neuroendocrine tumours, and Octreotide-based radioactive conjugates have been leveraged clinically to detect small neuroendocrine tumour sites.
Mingliang, Fan, Yue, Huang, Xinlin, Zhu, Jiayu, Zheng, Mingwei, Du   +4 more
openaire   +2 more sources

Octreotide

Reactions Weekly, 2023
  +4 more sources

Octreotide

Reactions Weekly, 2021
  +4 more sources

Octreotid

DMW - Deutsche Medizinische Wochenschrift, 2009
S. Herzig, H. Mönig
openaire   +1 more source

Octreotide

Reactions Weekly, 2022
openaire   +2 more sources

Octreotide

Reactions Weekly, 2012
  +4 more sources